Genourob Overview

  • Founded
  • 2005

Founded
  • Status
  • Private

  • Employees
  • 21

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $105K

  • Investors
  • 3

Genourob General Information

Description

Manufacturer of medical devices designed to offer treatment of ligament lesions. The company's devices are used for the evaluation of the state and performance of the ligamentous structures of the knee, enabling orthopedic surgeons, sports doctors, and physiotherapists to get support in their day-to-day work during the full process of a patient's medical care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • Bâtiment 60
  • Rue du Chef Bataillon Henri Géret
  • 53000 Laval
  • France
+33 02 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genourob Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 20-Jun-2019 $105K 00.00 00.000 Completed Generating Revenue
4. Angel (individual) 29-Dec-2017 00000 00000 00.000 Completed Generating Revenue
3. Secondary Transaction - Private 00000 Completed Generating Revenue
2. Later Stage VC 01-Mar-2015 $487K $884K 00.000 Completed Generating Revenue
1. Later Stage VC 01-Jan-2011 $397K $397K 000000 Completed Generating Revenue
To view Genourob’s complete valuation and funding history, request access »

Genourob Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares 0,000 000.00 000.00 00 000.00 0.000
Ordinary Shares 0,000 000.00 000.00 00 000.00 0.000
P Shares 47,213 $17.36 $17.36 1x $17.36 30.73%
To view Genourob’s complete cap table history, request access »

Genourob Patents

Genourob Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3114020-B1 Method and apparatus for the detection and therapeutic monitoring of knee ligament injuries Active 15-Sep-2020 0000000000
FR-3114020-A1 Method and apparatus for the detection and therapeutic monitoring of knee ligament injuries Active 15-Sep-2020 0000000000 0
EP-2699160-A1 Apparatus and method for detecting a partial lesion of the anterior cruciate ligament of the knee Active 22-Apr-2011 00000000
EP-2699160-B1 Apparatus for detecting a partial lesion of the anterior cruciate ligament of the knee Active 22-Apr-2011 00000000
FR-2974286-B1 Apparatus and method for detecting partial lesion of cross ligament anterior knee Inactive 22-Apr-2011 A61B5/11
To view Genourob’s complete patent history, request access »

Genourob Executive Team (2)

Name Title Board Seat Contact Info
Stephane Nouveau Co-Founder, President & Chief Executive Officer
Henry Robert Ph.D Executive, Research & Development
To view Genourob’s complete executive team members history, request access »

Genourob Board Members (1)

Name Representing Role Since
Bertrand Distinguin GO Capital (France) Board Member 000 0000
To view Genourob’s complete board members history, request access »

Genourob Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genourob Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pays de la Loire Participations Venture Capital Minority 000 0000 000000 0
Ventures West Capital Venture Capital Minority 000 0000 000000 0
Siparex Group PE/Buyout Minority 000 0000 000000 0
To view Genourob’s complete investors history, request access »